EVOKE WEALTH, LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 159 filers reported holding REVANCE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
EVOKE WEALTH, LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$8,000
+100.0%
3000.0%0.00%
Q2 2022$4,000
+100.0%
300
+160.9%
0.00%
Q4 2021$2,000
-33.3%
1150.0%0.00%
Q3 2021$3,0000.0%1150.0%0.00%
Q2 2021$3,0000.0%1150.0%0.00%
Q1 2021$3,0000.0%1150.0%0.00%
Q4 2020$3,0000.0%1150.0%0.00%
Q3 2020$3,0000.0%1150.0%0.00%
Q2 2020$3,000
-100.0%
115
-73.0%
0.00%
-100.0%
Q4 2019$6,914,000
+24.8%
4260.0%0.00%0.0%
Q3 2019$5,538,0004260.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$52,671,00026.22%
NovaQuest Capital Management, L.L.C. 1,558,426$24,561,00022.85%
Sio Capital Management, LLC 254,581$4,012,0001.08%
ArrowMark Colorado Holdings LLC 3,409,217$53,729,0000.51%
Fosun International Ltd 472,532$7,447,0000.47%
Rhenman & Partners Asset Management AB 193,181$3,045,0000.36%
Phoenix Investment Adviser LLC 4,900$77,0000.17%
HARBOURVEST PARTNERS LLC 26,565$419,0000.15%
Quinn Opportunity Partners LLC 56,672$893,0000.12%
MFN Partners Management, LP 46,000$725,0000.12%
View complete list of REVANCE THERAPEUTICS INC shareholders